FY2026 March Earnings Explanation Materials

Performance Overview

Consolidated performance for FY2026 shows net sales of 125.6 billion yen (up 3.4% YoY), operating profit of 10.2 billion 36 million yen (up 2.2% YoY), ordinary income of 11.0 billion 21 million yen (up 15.2% YoY), and net income attributable to owners of the parent of 5.9 billion 16 million yen (up 5.7% YoY). The main revenue growth driver was the Vision Care Business, supported by increased supply volume of 1DAY products and expanded overseas sales. Conversely, the Healthcare & Lifecare Business saw a decline due to a decrease in the food segment. EBITDA rose significantly to 21.0 billion 54 million yen (up 14.1% YoY), with an operating profit margin of 8.1%.

Business Trends and Future Outlook

The Vision Care Business recorded net sales of 116.5 billion 23 million yen (up 3.7% YoY), with continued expansion of domestic and international sales of 1DAY products. Overseas sales increased notably through mass retailers in Europe and the U.S., as well as major e-commerce sites in China. The orthokeratology-related segment remained flat due to economic stagnation and intensified competition in China. The Healthcare & Lifecare Business posted net sales of 9.0 billion 81 million yen (down 0.9% YoY), impacted by a reduction in the food segment, but the Lifecare-related businesses, such as composting, remained flat. The company plans to continue growth investments, including preparations for new factories and human resource enhancements.